UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Vericiguat, a novel sGC stimulator: Mechanism of action, clinical, and translational science

Clinical and translational science, 2023-12, Vol.16 (12), p.2458-2466

2023

Volltextzugriff (PDF)

Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor

European journal of clinical pharmacology, 2016-09, Vol.72 (9), p.1065-1073

2016

Volltextzugriff (PDF)

Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, a Corticosteroid Capable of Inhibiting VEGF Expression

Investigative ophthalmology & visual science, 2003-03, Vol.44 (3), p.1192-1201

2003

Volltextzugriff (PDF)

Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model

European journal of pharmacology, 2005-03, Vol.511 (2), p.191-198

2005

Volltextzugriff (PDF)

Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE2, VEGF, and Vascular Leakage

Investigative ophthalmology & visual science, 2006-03, Vol.47 (3), p.1149-1160

2006

Volltextzugriff (PDF)

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function[S]

Journal of lipid research, 2011-02, Vol.52 (2), p.361-373

2011

Volltextzugriff (PDF)

Artificial intelligence inferred microstructural properties from voltage–capacity curves

Scientific reports, 2022-08, Vol.12 (1), p.13421-13421, Article 13421

2022

Volltextzugriff (PDF)

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

European journal of pharmacology, 2003-01, Vol.458 (3), p.283-289

2003

Volltextzugriff (PDF)

Performance benchmarks for open source porous electrode theory models

Heliyon, 2024-04, Vol.10 (7), p.e27830-e27830, Article e27830

2024

Volltextzugriff (PDF)

Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration

Pharmaceutical research, 2004-10, Vol.21 (10), p.1797-1804

2004

Volltextzugriff (PDF)

Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM)

Journal of ocular pharmacology and therapeutics, 2009-04, Vol.25 (2), p.97

2009

Volltextzugriff (PDF)

Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor

Clinical pharmacokinetics, 2017-12, Vol.56 (12), p.1461-1478

2017

Volltextzugriff (PDF)

Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: An anionic aldose reductase inhibitor

Brain research bulletin, 2010-02, Vol.81 (2), p.327-332

2010

Volltextzugriff (PDF)

Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells

European journal of pharmacology, 2002-08, Vol.449 (3), p.213-220

2002

Volltextzugriff (PDF)

Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects

Current medical research and opinion, 2007-12, Vol.23 (12), p.2913-2920

2007

Volltextzugriff (PDF)

Evaluation of food effect on the oral bioavailability of pradigastat, a diacylglycerol acyltransferase 1 inhibitor

Biopharmaceutics & drug disposition, 2015-10, Vol.36 (7), p.452-461

2015

Volltextzugriff (PDF)

Effect of Clopidogrel on the Steady-State Pharmacokinetics of Fluvastatin

Journal of clinical pharmacology, 2007-05, Vol.47 (5), p.613-619

2007

Volltextzugriff (PDF)

Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells

Journal of pharmacy and pharmacology, 2003-09, Vol.55 (9), p.1199-1206

2003

Volltextzugriff (PDF)

Artificial intelligence inferred microstructural properties from voltage–capacity curves

Scientific reports, 2022-08, Vol.12 (1)

2022

Volltextzugriff (PDF)

The effect of LCZ696 (sacubitril/valsartan) on amyloid‐β concentrations in cerebrospinal fluid in healthy subjects

British journal of clinical pharmacology, 2016-05, Vol.81 (5), p.878-890

2016

Volltextzugriff (PDF)

Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor–Neprilysin Inhibitor

Clinical pharmacokinetics, 2018, Vol.57 (1), p.105-123

2018

Volltextzugriff (PDF)

Effect of the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide

British journal of clinical pharmacology, 2018-05, Vol.84 (5), p.926-936

2018

Volltextzugriff (PDF)

Data-driven autoencoder neural network for onboard BMS Lithium-ion battery degradation prediction

Journal of energy storage, 2024-03, Vol.82, p.110575, Article 110575

2024

Volltextzugriff (PDF)

Evaluation of Drug-Drug Interaction Potential Between Sacubitril/Valsartan (LCZ696) and Statins Using a Physiologically Based Pharmacokinetic Model

Journal of pharmaceutical sciences, 2017-05, Vol.106 (5), p.1439-1451

2017

Volltextzugriff (PDF)

Intratracheal budesonide-poly (lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model

Journal of pharmacy and pharmacology, 2005-07, Vol.57 (7), p.851-860

2005

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(44)
Dissertationen
(2)

Sprache

Englisch
(46)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(34)
Pharmacology & Pharmacy
(27)
Humans
(26)
Male
(22)
Adult
(17)
Female
(15)
Middle Aged
(15)
Drug Combinations
(13)
Pharmacokinetics
(12)
Tetrazoles - Pharmacokinetics
(12)
Aminobutyrates - Pharmacokinetics
(11)
Animals
(11)
Angiotensin Receptor Antagonists - Pharmacokinetics
(10)
Adolescent
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Rats
(9)
Rats, Sprague-Dawley
(9)
Drug Interactions
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vericiguat, a novel sGC stimulator: Mechanism of action, clinical, and translational science

Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor

Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, a Corticosteroid Capable of Inhibiting VEGF Expression

Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model

Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE2, VEGF, and Vascular Leakage

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function[S]

Artificial intelligence inferred microstructural properties from voltage–capacity curves

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

Performance benchmarks for open source porous electrode theory models

Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration

Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM)

Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor

Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: An anionic aldose reductase inhibitor

Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells

Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects

Evaluation of food effect on the oral bioavailability of pradigastat, a diacylglycerol acyltransferase 1 inhibitor

Effect of Clopidogrel on the Steady-State Pharmacokinetics of Fluvastatin

Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells

Artificial intelligence inferred microstructural properties from voltage–capacity curves

The effect of LCZ696 (sacubitril/valsartan) on amyloid‐β concentrations in cerebrospinal fluid in healthy subjects

Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor–Neprilysin Inhibitor

Effect of the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide

Data-driven autoencoder neural network for onboard BMS Lithium-ion battery degradation prediction

Evaluation of Drug-Drug Interaction Potential Between Sacubitril/Valsartan (LCZ696) and Statins Using a Physiologically Based Pharmacokinetic Model

Intratracheal budesonide-poly (lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model

Suchergebnisse filtern